INS and Hyperglycemia: In whole-body NEU3-overexpressing transgenic mice, insulin signaling is attenuated, with reduced phosphorylation of the insulin receptor and downstream targets such as IRS-1 and Akt, leading to glucose intolerance and fasting hyperglycemia.